Sign Up to like & get
recommendations!
0
Published in 2019 at "British Journal of Surgery"
DOI: 10.1002/bjs.11301
Abstract: Immune checkpoint inhibitors, such as antibody against programmed cell death protein (PD‐1), have demonstrated antitumour effects in patients with malignancies, including oesophageal cancer. A lymphocytic reaction observed by pathological examination is a manifestation of the…
read more here.
Keywords:
lymphocytic reaction;
prognosis;
oesophageal cancer;